TerXT is a combination of xanomeline and trospium prodrugs for the treatment of schizophrenia, and intends to pursue accelerated 505(b)(2) approval pathway Miami, FL – May 20, 2024 – Terran Biosciences Inc. (“Terran”), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has announced the development of TerXT, a combination of…
Framing chores as learning opportunities encourages child autonomy, study shows
Parents are much less likely to intervene when their young children are getting dressed or performing other simple chores if those tasks are framed as
November 24, 2024